M&A: large deals ($1bn+)

Michael Aiello

Partner

Scott A. Barshay

Click here for attorney bio.

Mark Greene

Mark I. Greene is the Head of Cravath’s Corporate Department and the Leader of the Firm’s International Practice. His practice focuses on mergers and acquisitions, corporate governance and securities matters, including advising on cross-border and domestic transactions, private equity deals, complex restructuring transactions, proxy fights, takeover defense and hedge fund activism. According to clients and the market, Mr. Greene has a “mighty reputation in cross-border deals” and “outstanding and deep experience in M&A.” He “treats his clients as priority number one” and “takes time to probe and understand his clients’ objectives and is very practical in the legal advice he offers.” 

Richard Hall

Partner

Lee Meyerson

Chair of global Financial Institutions Practice and previous head of global M&A practice. Representations include Toronto-Dominion Bank’s First Horizon acquisition ($13.4 billion) and TD Ameritrade/The Charles Schwab sale ($26 billion); U.S. Bancorp/Union Bank acquisition ($8 billion); TCF Financial/Chemical merger ($3.5 billion) and TCF/Huntington merger ($6 billion); ADS/Bread acquisition ($450 million); People’s United’s sale to M&T ($7.4 billion) and multiple regional bank acquisitions ($2 billion total); IBERIABANK/First Horizon merger ($3.9 billion); WMH/Nationstar Mortgage merger ($3.8 billion); Fifth Third/MB Financial merger ($4.7 billion); Synovus/FCB Financial acquisition ($2.9 billion); KeyCorp/First Niagara acquisition ($4.1 billion); Petrohawk/BHP sale ($15.1 billion); JPMorgan/Bank One merger ($58 billion) and commodities business sale ($3.5 billion); Mellon/BONY merger ($16.8 billion); Toronto-Dominion in $33 billion of U.S. acquisitions; U.S. Treasury $250 billion TARP; Schwab/optionsXpress acquisition ($1 billion). Practice includes financial institutions IPOs, securities offerings.

Faiza Saeed

Faiza J. Saeed is Cravath’s Presiding Partner. She advises public companies, boards of directors and special committees in connection with M&A, corporate governance and crisis management, including takeover defense and proxy contests.

Daniel Wolf

Daniel focuses on mergers and acquisitions, representing public and private companies and private equity firms in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity, including many significant cross-border and contested transactions, as well as representing boards of directors in activism defense and governance matters. Clients he has represented include Bristol-Myers Squibb, Blackstone Group, Vista Equity Partners, Celanese, Fortive, Avis Budget, Teva Pharmaceutical, GrubHub, Ventas, Akzo Nobel and GSK.

George Casey

Partner

Joshua Apfelroth

Joshua Apfelroth is a partner in Proskauer's Private Equity and Mergers & Acquisitions Group. Josh’s practice involves advising a diversified mix of corporations, private equity funds, hedge funds, investment bank and family office clients on complex corporate transactional issues, including public and private mergers acquisitions and dispositions, corporate governance, contests for corporate control, tender and exchange offers, spinoffs and joint ventures.  Josh also advises growth companies and investors in connection with venture capital and other alternative investments.  In addition, Josh advises clients on complex transactions involving distressed companies and assets, including restructurings, financings, investments, and mergers and acquisitions. Josh represents clients across a broad range of industries, including in the infrastructure, technology, media and entertainment, pharmaceutical, life sciences, real estate and financial services sectors.  Clients trust Josh to serve as a day-to-day legal advisor advising them on a wide array of governance, securities and other commercial matters, including directors’ duties and responsibilities, board composition, public disclosure, and legal compliance.

Laura Delanoy

Please see https://www.willkie.com/professionals/d/delanoy-laura-l

Sebastian Fain

Partner

Jenny Hochenberg

Laura C. Turano

Click here for attorney bio.  

Barbara Becker

Barbara L. Becker is Chair and Managing Partner of Gibson, Dunn & Crutcher.  Prior to her election to this role, Barbara served as Co-Chair of Gibson Dunn’s Mergers and Acquisitions Practice Group for over a decade, and also created and led the firmwide Diversity Committee. Barbara Becker advises public companies, boards of directors and special committees on M&A, corporate governance and strategic matters. Her clients include Accenture, General Electric Company, Kraft Heinz, Merck, News Corp., PepsiCo, VMware, Xylem, and investment banks, including Centerview, Guggenheim and Lazard.

Lauren Boglivi

Lauren Boglivi is the co-chair of Proskauer's Corporate Department and co-head of Proskauer’s global Mergers & Acquisitions and Private Equity Group. Through her extensive transactional experience, Lauren is a leading lawyer at the forefront of some of the most industry-defining M&A matters, particularly in the health care, media and entertainment, and gaming industries. Lauren advises both private and public companies, including private equity sponsors and family offices, in their most critical and complex deals. In working with influential and high-profile media giants, Lauren has worked extensively on transactions that structure and shape the way media content is viewed and accessed around the world. Lauren’s recent deal activity includes: Represented media giant Discovery in a variety of matters that have made headlines around the world, including its sale of Great American Country Network, its acquisition of Golf Digest, one of the world’s leading golf media brands, from Condé Nast, its $2 billion strategic alliance with the PGA Tour, its spinoff and equity investment in Curiousity.com, Sale of Discovery Education business for $120 million sale to Francisco Partners, a private equity firm Representing Ethos Veterinary Health, one of the industry’s most innovative veterinary organizations, in its pending acquisition by National Veterinary Associates (NVA), a leading global community of nearly 1,200 veterinary hospitals. Represented WestMed Medical Group, a multispecialty medical practice of nearly 500 physicians and advanced care providers and 1,500 clinical employees located in Westchester County, NY and Fairfield County, CT, in its combination with Summit Health, a company formed by the merger of CityMD and Summit Medical Group.  Summit Health now includes more than 2,500 providers, 12,000 employees and over 340 locations in NJ, NY, CT, PA and central OR.  Summit Health is a portfolio company of Warburg Pincus. Represented Blade Urban Mobility, Inc. in its $825 million de-SPAC business combination with KSL Capital’s SPAC - Experience Investment Corp. Represented Hearst’s healthcare subsidiary, Homecare Homebase, in its acquisition of CellTrak Technologies, a leading provider of care documentation software solutions in the personal care market. Represented Hearst Magazines in its sale of Marie Claire U.S. to British media company Future. Represented Harren Equity Partners, LLC in connection with the sale of its portfolio company, Health Connect America, Inc., to Palladium Equity Partners V, L.P. Represented Beacon Orthopaedics & Sports Medicine in the launch of a national management services organization (MSO) formed with an investment from Revelstoke Capital Partners. Represented Public Interest Registry (PIR), which was established by the Internet Society in 2002 to manage and operate the .ORG domain, in $1.135 billion sale to Ethos Capital, which was terminated by mutual agreement. Led the Proskauer team that advised Empire City Casino, one of the largest gaming facilities in the U.S. and one of only two facilities licensed to operate video lottery terminals in the New York City metropolitan area, in its $850 million sale to MGM Resorts International.

Ting Chen

Ting S. Chen is a partner in Cravath’s Corporate Department. Her practice focuses on mergers and acquisitions, corporate governance, and activism and takeover defense. Ms. Chen’s clients have included Avon, BDT Capital Partners, British American Tobacco, DHT, DreamWorks Animation, Goldman Sachs, Honeywell, IBM, Illumina, InterMune, JPMorgan Chase, Kraft, Lundbeck, New Senior, OneBeacon Insurance, Pitney Bowes, Qualcomm, Starbucks, Thermo Fisher Scientific, The Washington Post, White Mountains Insurance and Zale Corporation.

Jonathan Davis

Jonathan Davis’s practice primarily focuses on public and private company merger and acquisition transactions and activist defense. Jonathan also advises corporations and their directors on general corporate and governance matters. Over the course of his career, Jonathan has advised on transactions having an aggregate value of approximately $700 billion. His clients have included 3G Capital, AbbVie, Alliant Techsystems, Amcor, Anheuser Busch InBev, Avaya, Avon, Bristol-Myers Squibb, Delhaize Group, Fortive, General Motors, H.J. Heinz, Honeywell, IBM, J.Crew, Jones Group, Mead Johnson, Pentair, Pinnacle Foods, Scientific Games and Spectrum Brands, as well as numerous SPACs and investment banks.

Tad Freese

 Tad Freese represents a broad range of high technology companies, investment banks, and other public and private companies in their corporate transactions. He is the Managing Partner of Latham's Silicon Valley office, and was previously a Vice Chair of Latham's Global Corporate Department. 

Aaron Gruber

Aaron M. Gruber is a partner in Cravath’s Corporate Department. His practice primarily focuses on mergers and acquisitions, activist defense, corporate governance and general corporate matters.

Alan Klein

Alan is a Partner in the Firm's M&A Practice and until recently served as Co-Head of the Practice. Represented the board of Twitter in the company’s sale to Elon Musk. Advised Microsoft on many transactions, including its acquisition of Activision as well as LinkedIn, Skype, and many others; ChemChina in its acquisition of Syngenta, the largest acquisition ever by a Chinese company; Tyco in its merger with Johnson Controls, Inc.; and numerous other companies in cutting-edge transactions including Cisco, ADT, Best Buy, Wendy’s and Royal Ahold. He has also advised the boards of public companies including Aetna, Xerox, Yahoo and Baker Hughes, among others, on corporate governance matters.

Ethan Klingsberg

Partner

James Langston

Partner

Clare O'Brien

Partner

Mario Ponce

Partner in the Corporate Department. Focuses on negotiated and hostile merger and acquisition transactions, proxy contests, restructurings, joint ventures, corporate governance and shareholder activism. Represents both public and private companies in a variety of industries and advises private equity clients. Counsel to boards of directors and special committees concerning corporate governance, fiduciary duties and other matters. Has significant experience in the energy, industrials, retail and healthcare industries.

John Reiss

Partner

Charles Ruck

Charles Ruck practices in the Orange County and New York offices. Mr. Ruck's practice focuses on mergers and acquisitions, capital markets, and general corporate and securities matters. He serves as primary outside counsel to a number of public and privately held companies and he regularly represents boards of directors and special committees in complex strategic corporate governance matters. Mr. Ruck is a former member of Latham & Watkins' Executive Committee and Chair of the firm's Strategic Client Initiative.

George Schoen

George F. Schoen is a partner in Cravath’s Corporate Department. His practice focuses primarily on mergers, acquisitions and joint ventures, including hostile and contested transactions. He also regularly counsels corporations and their directors on fiduciary duty and corporate governance matters.

Eric Swedenburg

Head of Simpson Thacher’s Mergers and Acquisitions Practice and a member of the Executive Committee, Eric Swedenburg represents companies in a wide range of mergers, acquisitions and divestitures, spin-offs, joint ventures and other significant corporate transactions. He also regularly counsels clients on shareholder activism, corporate governance and general corporate and securities law matters. In addition to his significant amount of work with public companies, Eric has extensive experience in advising special committees of boards of directors, private equity firms and financial advisors in both U.S. domestic and cross-border M&A transactions across a number of industry verticals. Some of his transactions have included representing AGCO, Change Healthcare, Dover, Genesee & Wyoming, Ingersoll Rand, K2M, Karuna Therapeutics, La Quinta, Mars, McKesson, SiriusXM, The Mosaic Company, Vodafone Group, Wendy’s and Wyeth. Eric has published various articles on M&A subjects and frequently speaks on M&A, shareholder activism and corporate matters, including as a regular panel participant in the annual Tulane Corporate Law Institute, which is recognized as one of the premier M&A, corporate and securities law conferences in the country.

Adam Turteltaub

Please see https://www.willkie.com/professionals/t/turteltaub-adam-m

Damien Zoubek

Partner, Co-Head of US Corporate and M&A